Skip to content
NeuroDeRisk
NeuroDeRisk
Neurotoxicity De-Risking in Preclinical Drug Discovery
  • Home
  • Consortium
    • Consortium Partners
    • Scientific Advisory Board
  • Neurotoxicity
  • News
  • Q & A
  • Contact
  • Search
  • Home
  • Consortium
    • Consortium Partners
    • Scientific Advisory Board
  • Neurotoxicity
  • News
  • Q & A
  • Contact
  • Search

Tag: COVID-19

First Year Anniversary Meeting held online

First Year Anniversary Meeting held online

April 24, 2020 May 5, 2020

Monday, April 27, 2020 – Tuesday, April 28, 2020, @homeoffice. Due to the current situation regarding the Corona Virus (COVID-19) and the worldwide travel restrictions, we are unfortunately forced to …

 #StayAtHome | Anniversary | Consortium Meeting | COVID-19 | First Year | NeuroDeRisk | Online
Read more"First Year Anniversary Meeting held online"

Academic Project Coordinator

Thierry Langer, University of Vienna

EFPIA – Project Leader

Jacques Richard, Sanofi

The NeuroDeRisk project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 821528.
This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.

innovative medicines initiative
European Union
efpia
  • Imprint-
  • Disclaimer-
  • Privacy Policy-
Back to Top

© 2020 NeuroDeRisk

Do NOT follow this link or you will be banned from the site!